Background::
Carpal tunnel syndrome (CTS) is a condition that is caused by medial
nerve compression, resulting in symptoms such as numbness, tightness, or weakness in the hand.
Objectives::
The aim of the study was to find out the genetic modulation, mechanism, available
treatment, and recommendation for carpal tunnel syndrome at its specific stage.
Methods::
Almost 200 papers were searched for this review article, and 145 articles were selected.
The literature was collected from different sources like Google scholar, PubMed, a directory of
open-access journals, and science.gov by using keywords, such as treatment, risk factors, recommendation,
and clinical features of carpal tunnel syndrome.
Results::
The most efficient non-surgical treatment is methylprednisolone acetate, which reduces
inflammation by acting on the glucocorticoid receptor in conjunction with immunofilling. It has also
been used successfully as a second-line drug for the treatment of patients with mild or moderate
conditions in order to provide relief. New non-pharmacological options include laser therapy
in acupuncture, transcutaneous electric nerve stimulation (TENS), and sham therapy. Modern treatments
like TENS, laser therapy, splints, and injections of methylprednisolone acetate have been
demonstrated to be helpful in sporadic situations. For patients with mild and moderate problems,
more research should be conducted that includes the combination of these surgical and non-surgical
treatments.
Conclusion::
We propose a multifunctional panel construct and define standard data items for future
research into carpal tunnel syndrome. A discussion on idiopathic carpal tunnel syndrome, risk
factors, combination of therapies, using guidelines-based recommendations and treatment should
be initiated.